NEWS

Princeton, NJ, April 14, 2008 — JFK Communications Inc., a Princeton-based healthcare public relations firm, welcomes Stephen C. Bingham, a 20-year healthcare communications veteran, as vice president.  JFK Communications has been experiencing double-digit growth for the last four years and looks forward to Bingham managing the growing client roster. 

Bingham will oversee JFK’s growing list of pharmaceutical, specialty pharma and medical technology clients, including Eisai Inc., Aerocrine, Inc., NPS Pharmaceuticals and Cytogen Corporation.  

“We are very excited to have a senior executive of Stephen’s caliber join our team as vice president at JFK Communications,” said John F. Kouten, Chief Executive Officer.  “His prior experience with pharmaceutical and biotechnology clients, as well as his successful track record in managing PR firms, will be a valuable asset to our clients and to the firm.”

Prior to JFK Communications, Bingham worked as a senior member of the Caunos Group, where he supported corporate communications activities for clients including Novartis OTC and Novartis Pharmaceuticals, in addition to bringing in new business from clients such as Johnson & Johnson. 

Bingham previously ran his own firm, Bingham Associates, based in Toronto and Washington, D.C.  His clients included Becton Dickinson, GlaxoSmithKline, and Pharmacia Corporation.

Additionally, Bingham served as an adjunct professor at the State University of New York’s Buffalo campus, where he taught public relations, corporate communications and writing.

JFK Communications, Inc. provides innovative public relations solutions for the pharmaceutical, biotechnology and medical technology industries.  For more information on JFK Communications’ capabilities or career opportunities, please visit www.jfkhealth.com or call (609) 514-5117.